US2020216852A1PendingUtilityA1
Method for Producing Recombinant 11-De-O-Methyltomaymycin
Est. expiryMay 14, 2032(~5.8 yrs left)· nominal 20-yr term from priority
A61K 31/445C12N 15/66C12N 15/102C12N 15/52C07D 519/00C12N 15/76C07K 14/36C07D 487/04
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a tomaymycin biosynthetic gene cluster of Streptomyces species FH6421, and its use for producing 11-de-O-methyltomaymycm.
Claims
exact text as granted — not AI-modified1 . A nucleic acid molecule comprising at least one nucleic acid selected from the group consisting of:
(a) a nucleic acid comprising at least one of the Open Reading Frames (ORFs) 1 to 19 of SEQ ID NO: 2 that encodes proteins of SEQ ID NOs: 4 to 22 or a variant or fragment thereof, whereby the variant or fragment encodes a functionally active variant or fragment of a protein of SEQ ID NOs: 4 to 22, (b) a nucleic acid encoding at least one of the proteins of SEQ ID NOs: 4 to 22 or a functionally active variant or fragment thereof, (c) a nucleic acid encoding a protein that is at least 70%, 80%, 90%, 95% or 97% identical in amino acid sequence to a protein or fragment thereof encoded by the nucleic acid of (a) or (b), (d) a nucleic acid that hybridizes under stringent conditions with a nucleic acid of (a) to (c), (e) a nucleic acid that is complementary to a nucleic acid of (a) to (d).
2 . The nucleic acid according to claim 1 comprising the tomaymycin biosynthetic gene cluster of SEQ ID NO: 2 or having a variant or fragment sequence of SEQ ID NO: 2 harboring a variant or fragment of at least one of ORFs 1 to 19, whereby the variant or fragment encodes a functionally active variant or fragment of a protein of SEQ ID NOs: 4 to 22.
3 . An expression vector comprising a nucleic acid of claim 1 .
4 . A cell comprising the expression vector according to claim 3 .
5 . The cell of claim 4 , wherein the cell is Streptomyces species FH6421.
6 . A method for producing a cell that harbors a tomaymycin biosynthetic gene cluster or a functionally active variant or fragment thereof.
7 . The method according to claim 6 , wherein the cell harbors the tomaymycin biosynthetic gene cluster of SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3, or a functionally active variant or fragment thereof.
8 . The method according to claim 7 , wherein the cell is a Streptomyces strain harboring the tomaymycin biosynthetic gene cluster of SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3, or a functionally active variant or fragment thereof.
9 . The method according to claim 8 , wherein the Streptomyces strain is selected from the group consisting of Streptomyces achromogenes var. tomaymyceticus, Streptomyces species FH6421, and Streptomyces albus /pStW102tc.
10 . The method according to claim 6 , wherein the cell harbors at least one ORF of SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3, or functionally active variant or fragment thereof, and is capable of producing 11-de-O-methyltomaymycin.Join the waitlist — get patent alerts
Track US2020216852A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.